[PE21-1] Three-year outcomes of oral immunotherapy using dried egg powder for severe hen's egg allergy

Koki Sasamoto¹, Ken-ichi Nagakura¹, Noriyuki Yanagida¹, Sakura Sato², Motohiro Ebisawa² (1.Department of Pediatrics, National Hospital Organization Sagamihara National Hospital, Japan, 2.Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan)

[PE21-2] Safety of ultralow-dose of antigen oral immunotherapy in pediatric patients with severe peanut allergy: induction, fixed-dose, and escalation phases

Kyoko S Nishikage^1,2, Takeharu Yamanaka² (1.Yokohama Nishikage Clinic:kids and allergies, Japan, 2.Department of Biostatistics, School of Medicine, Yokohama City University, Japan)

[PE21-3] Comparison of the efficacies of low-dose and high-dose slow oral immunotherapy for egg allergy

Yuri Takaoka, Junko Kumon, Tomohiro Yamaguchi, Rumi Ueno, Yuki Tsurinaga, Tamana Nakano, Yohei Fukasawa, Amane Shigekawa, Yukinori Yoshida, Makoto Kameda (Department of Pediatrics, Osaka Habikino Medical Center, Japan)

[PE21-4] Low achievement of sustained unresponsiveness in oral immunotherapy for persistent cow's milk allergy

Toshinori Nakamura, Kosei Yamashita, Yuki Okada, Mayu Maeda, Taro Kamiya, Takanori Imai (Department of Pediatrics, Showa University School of Medicine, Japan)

[PE21-5] Food allergy and oral immunotherapy affect food preferences

Kenji Toyokuni, Kiwako Yamamoto-Hanada, Yoshitsune Miyagi, Hiroya Ogita, Tomoyuki Kiguchi, Yusuke Inuzuka, Koji Nishimura, Fumi Ishikawa, Makoto Irahara, Miori Sato, Mayako Saito-Abe, Yumiko Miyaji, Shigenori Kabashima, Tatsuki Fukuie, Yukihiro Ohya (Allergy Center, National Center for Child Health and Development, Japan)

[PE21-6] Long-term quality of life of persistent food allergy patients in post oral immunotherapy

Kosei Yamashita, Toshinori Nakamura, Toshiyuki Takagi, Yuki Okada, Mayu Maeda, Taro Kamiya, Takanori Imai, Katsumi Mizuno (Department of Pediatrics, Showa University School of Medicine, Japan)

[PE21-7] Effectiveness and safety of rush and slow oral immunotherapy in our facility

Tomonori Kadowaki, Yukiko Otsuka, Yuki Okada, Kanako Maruta, Kumiko Miyazaki, Yuko Shimokawa, Koji Tatebayashi, Michinori Funato, Hideo Kaneko (Department of Pediatrics, National Hospital Organization Nagara Medical Center, Japan)

[PE21-8] Factors associated with the safety of initials dose of slow low-dose oral immunotherapy

Shiro Sugiura, Katsumasa Kitamura, Teruaki Matsui, Yoshihiro Takasato, Komei Ito (Department of Allergy, Aichi Children's Health and Medical Center, Japan)

[PE21-9] Examination of the long-term effect of oral immunotherapy in children with cow's milk allergy

Ryohei Suzuki, Yuriko Sekiguchi, Nagatoshi Sagara, Akiko Aota, Kenichi Akashi, Toshio Katsunuma (Department of Pediatrics, Daisan Hospital, The Jikei University School of Medicine, Japan)

[PE21-10] Exercise-induced allergic reactions after achievement of desensitization to cow's milk and wheat

Shohei Kubota, Katsumasa Kitamura, Teruaki Matsui, Yasuhiro Takasato, Shiro Sugiura, Komei Ito (Department of Allergy, Aichi Children's Health and Medical Center, Japan)

[PE21-11] Factors related to treatment outcome and adverse events in peanut rush oral immunotherapy

Tomonori Ishiguro, Katsumasa Kitamura, Yoshihiro Takasato, Teruaki Matsui, Shiro Sugiura, Komei Ito (Department of Allergy, Aichi Children's Health and Medical Center, Japan)

[PE21-12] Exercise-induced allergic reactions on desensitization to cow's milk after rush oral immunotherapy

Genki Tsuji, Teruaki Matsui, Yoshihiro Takasato, Katsumasa Kitamura, Shiro Sugiura, Komei Ito (Department of Allergy, Aichi Children's Health and Medical Center, Japan)

[PE21-13] ω-5 gliadin-sIgE/total IgE predicts long-term outcome of low-dose OIT for severe wheat allergy

Ken-ichi Nagakura¹, Noriyuki Yanagida¹, Sakura Sato², Yoko Miura¹, Makoto Nishino¹, Kyohei Takahashi¹, Tomoyuki Asaumi¹, Kiyotake Ogura¹, Motohiro Ebisawa² (1.Department of Pediatrics, National Hospital Organization Sagamihara National Hospital, Japan, 2.Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan)

Cancelled

[PE21-15] Permanent tolerance induced by oral immunotherapy; is it a complete symptom-free condition? 6 month follow up after PT achievement

Morteza Fallahpour, Saba Arshi, Mohammad Nabavi, Mohammad Hasan Bemanian, Sima Shokri (Allergy & Clinical Immunology Department, Rasoul e Akram Hospital, Iran)

[PE21-16] Does oral immunotherapy for food allergy impact allergic chidren BMI?

Skander Larakeb¹, Carine Billard¹, Patricia Tome² (1.Department of Pediatrics, Meaux General Hospital, France, 2.Allergology Unit, Aulnay Sous Bois Hospital, France)

[PE21-17] Evaluation of the effectiveness of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome associated with soybean allergy

Masaaki Hamada¹, Masakazu Kagawa², Ichiro Tanaka¹ (1.Department of Pediatrics, Yao Municipal Hospital, Japan, 2.Department of Clinical Research Center, Yao Municipal Hospital, Japan)

[PE21-18] Real-world outcome of oral immunotherapy for food allergy

Miyuki Hoshi, Shingo Yamada, Mayumi Matsunaga, Kazutaka Nogami, Kana Hamada, Keigo Kainuma, Mizuho Nagao, Takao Fujisawa (Allergy Center, National Hospital Organization Mie National Hospital, Japan)

Session information

[PE21] Poster Session 21
Food allergy-Immunotherapy